Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s share price traded up 0.5% during mid-day trading on Thursday . The company traded as high as $48.77 and last traded at $48.77. 362 shares traded hands during trading, a decline of 57% from the average session volume of 850 shares. The stock had previously closed at $48.51.
Hikma Pharmaceuticals Stock Performance
The company’s 50 day moving average is $49.49 and its 200-day moving average is $50.08.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Micron Stock Under $100: Seize the AI-Driven Upside
- 3 Ways To Invest In Coffee, Other Than Drinking It
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
